Mabion (WAR:MAB) Total Stockholders Equity : zł129.3 Mil (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Mabion Total Stockholders Equity?

Mabion's Total Stockholders Equity for the quarter that ended in Sep. 2024 was zł129.3 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Mabion's Book Value per Share for the quarter that ended in Sep. 2024 was zł8.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Mabion's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.03.

Mabion Total Stockholders Equity Historical Data

The historical data trend for Mabion's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabion Total Stockholders Equity Chart

Mabion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

-21.58

-77.39

53.31

76.51

117.78

Mabion Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															119.08	117.78	135.32	145.61	129.32

Mabion (WAR:MAB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Mabion's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(129.316	-	0)	/	16.162
	=	8.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Mabion's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.728	+	2.007)	/	129.316
	=	0.03

Mabion Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Mabion's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mabion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabion SA (WAR:MAB) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Gen. Mariana Langiewicza 60, Konstantynow Lodzki, POL, 95-050

Website

https://www.mabion.eu

Mabion SA is a Polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. The drugs developed by the company are targeted treatments, characterized by the drug's ability to recognize the factor causing cancer and interact with this factor only. The company is working on the development of its main priority drug, referred to as the MabionCD20 drug. The therapeutic uses of MabionCD20 are for Non-Hodgkin's lymphoma, Leukemia, and Rheumatoid Arthritis.